Fertility and Sterility
Volume 94, Issue 3 , Pages 1105-1107 , August 2010

Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility

  • Miguel A. Checa, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Miguel A. Checa, M.D., Department of Obstetrics and Gynecology, Hospital Universitari del Mar, Passeig Marítim 25–29, E-08003 Barcelona, Spain (FAX: +34-93-2483254).
    • ,
  • Maria Prat, M.D.
    • ,
  • Ramón Carreras, M.D.

Received 24 July 2009 ,Revised 24 September 2009 ,Accepted 28 October 2009.

References 

  1. ESHRE Capri Workshop Group. Diagnosis and management of the infertile couple: missing information. Hum Reprod Update. 2004;10:295–307
  2. Collins JA, Corsignani PG. Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and management. Int J Gynecol Obstet. 1992;39:267–275
  3. Sher G, Knutzen VK, Stratton CJ, Montakhab MM, Allenson SG. In vitro sperm capacitation and transcervical intrauterine insemination for the treatment of refractory infertility: phase I. Fertil Steril. 1984;41:260–264
  4. Jones HW. Multiple births: how are we doing?. Fertil Steril. 2003;79:7–21
  5. Guzick DS, Carson SA, Coutifaris C, Overstreet JW. Efficacy of superovulation in intrauterine insemination in the treatment of infertility. N Engl J Med. 1999;340:177–183
  6. Tur R, Barri PN, Coroleu B, Buxaderas R, Parera N, Balasch J. Use of a prediction model for high-order multiple implantation after ovarian stimulation with gonadotropins. Fertil Steril. 2005;83:116–121
  7. Rizk B. Ovarian hyperstimulation syndrome—epidemiology, pathophysiology, prevention and management. New York: Cambridge University Press; 2006;10–33
  8. Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update. 2008;14:321–333
  9. Hock DL, Seifer DB, Kontopoulos E, Ananth CV. Practice patterns among board-certified reproductive endocrinologists regarding high-order multiple gestations: a United States national survey. Obstet Gynecol. 2002;99:763–770
  10. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Risk factors for higher order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation; results of 4,062 IUI cycles. Fertil Steril. 2005;83:671–683
  11. Sharif K, Elgendy M, Lashen H, Afnan M. Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynecol. 1998;105:107–112
  12. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291–301
  13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47
  14. Boekmans FJ Slaats P, Hendriks DJ, Mol BW. A systemic review of test predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718
  15. Ramalho de Carvalho B Japur C, Rosa JC, Dos Reis RM, Ferriani RA, Silva de Sa MF. Ovarian reserve evaluation: state of the art. J Assist Reprod Genet. 2008;25:311–322
  16. Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, et al. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. BJOG. 2003;110:1072–1077

 M.A.C. has nothing to disclose. M.P. has nothing to disclose. R.C. has nothing to disclose.

PII: S0015-0282(09)03984-3

doi: 10.1016/j.fertnstert.2009.10.063

Fertility and Sterility
Volume 94, Issue 3 , Pages 1105-1107 , August 2010

Article Tools

* Image Usage & Resolution